Literature DB >> 6649348

Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole.

J C Boray, P D Crowfoot, M B Strong, J R Allison, M Schellenbaum, M Von Orelli, G Sarasin.   

Abstract

A new benzimidazole anthelmintic, triclabendazole (CGA-89317) was found to be highly efficient against mature and early immature Fasciola hepatica infections in sheep. At the dose rate of 2.5 mg/kg the efficiency was 90 and 98 per cent against flukes aged eight and 12 weeks respectively. At 5 mg/kg the drug was 92 and 98 per cent efficient against flukes aged four and eight weeks respectively and 100 per cent against 12-week-old flukes. An efficiency of 93 and 98 per cent was achieved against one-week-old flukes and 99 to 100 per cent against flukes aged two to four weeks at 10 mg/kg. At this dose rate the drug had 100 per cent efficiency against six-week-old flukes. If the dose was increased to 15 mg/kg, 98 per cent efficiency was achieved one day after infection. Triclabendazole was equally efficient when administered orally or by intraruminal or intra-abomasal injection. The maximum tolerated dose of 200 mg/kg was established.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6649348     DOI: 10.1136/vr.113.14.315

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  32 in total

1.  Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheep.

Authors:  Luis A Gomez-Puerta; Cesar Gavidia; Maria T Lopez-Urbina; Hector H Garcia; Armando E Gonzalez
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Efficacy of an experimental fasciolicide against immature and mature Fasciola hepatica in artificially infected calves.

Authors:  Y Vera Montenegro; F Ibarra Velarde; E Liébano Hernández; H Quiroz Romero; R Castillo Bocanegra; A Hernández Campos; P Ochoa Galván
Journal:  Parasitol Res       Date:  2003-12-03       Impact factor: 2.289

3.  Biochemical characterization and differential expression of a 16.5-kilodalton tegument-associated antigen from the liver fluke Fasciola hepatica.

Authors:  José F Gaudier; Kimberly Cabán-Hernández; Antonio Osuna; Ana M Espino
Journal:  Clin Vaccine Immunol       Date:  2012-01-25

4.  Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.

Authors:  M McConville; G P Brennan; A Flanagan; R E B Hanna; H W J Edgar; R Castillo; A Hernández-Campos; I Fairweather
Journal:  Parasitol Res       Date:  2009-05-21       Impact factor: 2.289

5.  Fasciola hepatica: disruption of spermatogenesis by the fasciolicide compound alpha.

Authors:  Maeve McConville; Robert E B Hanna; Gerard P Brennan; Maurice McCoy; Hillary W J Edgar; Shirley McConnell; Rafael Castillo; Alicia Hernández-Campos; Ian Fairweather
Journal:  Parasitol Res       Date:  2009-11-18       Impact factor: 2.289

6.  Cathepsin L1 mimotopes with adjuvant Quil A induces a Th1/Th2 immune response and confers significant protection against Fasciola hepatica infection in goats.

Authors:  Abel Villa-Mancera; Alejandro Reynoso-Palomar; Fernando Utrera-Quintana; Lorenzo Carreón-Luna
Journal:  Parasitol Res       Date:  2013-11-12       Impact factor: 2.289

7.  In vitro efficacy of triclabendazole and clorsulon against the larval stage of Echinococcus multilocularis.

Authors:  David Richter; Joachim Richter; Beate Grüner; Kathrin Kranz; Juliane Franz; Peter Kern
Journal:  Parasitol Res       Date:  2013-02-28       Impact factor: 2.289

8.  Effectiveness of strategic anthelmintic treatments in the control of gastrointestinal nematodes and Fasciola gigantica in cattle in Iringa region, Tanzania.

Authors:  J D Keyyu; N C Kyvsgaard; J Monrad; A A Kassuku
Journal:  Trop Anim Health Prod       Date:  2008-03-19       Impact factor: 1.559

9.  Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes.

Authors:  Laura Ceballos; Laura Moreno; Luis Alvarez; Laura Shaw; Ian Fairweather; Carlos Lanusse
Journal:  BMC Vet Res       Date:  2010-02-03       Impact factor: 2.741

10.  Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

Authors:  A W Stitt; I Fairweather
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.